| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Sports Medicine Research Unit and 5 Department of Clinical Physiology, Bispebjerg Hospital, DK-2400 Copenhagen; 2 Copenhagen Muscle Research Center and 3 Department of Growth and Reproduction, Rigshospitalet, DK-2100 Copenhagen; and 4 Clinical Drug Development, Novo Nordisk, DK-2800 Bagsvaerd, Denmark
The present study investigated whether recombinant human (rh) growth hormone (GH) combined with endurance training would have a larger effect on oxidative capacity, metabolism, and body fat than endurance training alone. Sixteen healthy, elderly women, aged 75 yr, performed closely monitored endurance training on a cycle ergometer over 12 wk. rhGH was given in a randomized, double-blinded, placebo-controlled design in addition to the training program. GH administration resulted in a doubling of serum insulin-like growth factor I levels. With endurance training, peak oxygen uptake increased by ~18% in both groups, whereas the marked increase in muscle citrate synthase activity was 50% larger in the GH group compared with the placebo group. In addition, only the GH group revealed an increase in muscle L-3-hydroxyacyl-CoA dehydrogenase activity. Body weight remained unchanged in both groups, but the GH group showed significant changes in body composition with a decrease in fat mass and an increase in lean body mass. Twenty-four-hour indirect calorimetry performed in four subjects showed a marked increase in energy expenditure with increased relative and absolute fat combustion in the two subjects receiving rhGH. In conclusion, rhGH adds to the effects of endurance training on muscle oxidative enzymes and causes a reduction in body fat in elderly women.
insulin-like growth factor I; enzymes; exercise; calorimetry; body composition
This article has been cited by other articles:
|
|
 |
|
  G. Fanciulli, A. Delitala, and G. Delitala Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone Hum. Reprod. Update, May 1, 2009; 15(3): 341 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hansen, R. Morthorst, B. Larsson, A. Flyvbjerg, M. H. Rasmussen, H. Orskov, A. Astrup, M. Kjaer, and K. H. W. Lange Effects of 2 wk of GH administration on 24-h indirect calorimetry in young, healthy, lean men Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1030 - E1038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hansen, R. Morthorst, B. Larsson, R. Dall, A. Flyvbjerg, M. H. Rasmussen, H. Orskov, M. Kjaer, and K. H. W. Lange No effect of growth hormone administration on substrate oxidation during exercise in young, lean men J. Physiol., September 15, 2005; 567(3): 1035 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A J van der Lely Justified and unjustified use of growth hormone Postgrad. Med. J., October 1, 2004; 80(948): 577 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Schibler, R von der Heiden, P Birrer, and P E Mullis Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis Arch. Dis. Child., December 1, 2003; 88(12): 1078 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. W. Lange, J. Lorentsen, F. Isaksson, A. Juul, M. H. Rasmussen, N. J. Christensen, J. Bulow, and M. Kjar Endurance training and GH administration in elderly women: effects on abdominal adipose tissue lipolysis Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E886 - E897. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
